Botulinum Toxin

Botulinum Toxin

Therapeutic Clinical Practice and Science
2009, Pages 425-445
Botulinum Toxin

35 - Bungarotoxins

https://doi.org/10.1016/B978-1-4160-4928-9.00035-4Get rights and content

First page preview

First page preview
Click to open first page preview

References (0)

*

Dr. Kullman does not report any conflicts of interest. Dr. de Groat is disclosing that he has acted as a consultant for Allergen, Irvine, CA; Ethicon, Somerville, NJ; Procter and Gamble Pharmaceuticals, Mason, OH; Dynogen, Boston, MA; Puretech Ventures, Boston, MA; Hydra, Boston, MA; Medtronic, Minneapolis, MN. Dr. Artim does not report any conflicts of interest.

View full text